Results 71 to 80 of about 99,753 (275)

Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Journal of Clinical Oncology, 2013
PURPOSE The International Peripheral T-Cell Lymphoma Project was undertaken to better understand the subtypes of T-cell and natural killer (NK) -cell lymphomas.
M. Federico, T. Rudiger, M. Bellei, B. Nathwani, S. Luminari, B. Coiffier, N. Harris, E. Jaffe, S. Pileri, K. Savage, D. Weisenburger, J. Armitage, N. Mounier, J. Vose   +13 more
semanticscholar   +1 more source

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)

Cancers, 2022
Simple Summary Angioimmunoblastic T cell lymphoma (AITL) is the most common peripheral T cell lymphoma encountered in Europe. It is a non-Hodgkin’s lymphoma with a poor prognosis.
Racha Bahri, F. Boyer, M. Halabi, A. Chaunavel, J. Feuillard, A. Jaccard, S. Ranger-Rogez   +6 more
semanticscholar   +1 more source

RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells. [PDF]

, 2018
Research ...
Allen, G., Clavert, A., de Leval, L., Delarue, R., Dupuy, A., Fabiani, B., Fataccioli, V., Gaulard, P., Kataoka, K., Ko, Y.H., Lemonnier, F., Llamas-Gutierrez, F., Missiaglia, E., Ogawa, S., Ortonne, N., Rousselet, M.C., Thome, M., Vallois, D.   +17 more
core   +4 more sources

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

Proceedings of the National Academy of Sciences of the United States of America, 2016
Significance Mutations in isocitrate dehydrogenase (IDH)1 and IDH2 contribute to malignant progression by producing the oncometabolite 2HG. In myeloid disorders, mutations at three positions in these genes are commonly observed, but in angioimmunoblastic
F. Lemonnier, R. Cairns, S. Inoue, Wanda Li, A. Dupuy, S. Broutin, N. Martin, V. Fataccioli, R. Pelletier, A. Wakeham, B. Snow, L. de Leval, A. Pujals, C. Haioun, A. Paci, E. Tobin, R. Narayanaswamy, K. Yen, Shengfang Jin, P. Gaulard, T. Mak   +20 more
semanticscholar   +1 more source

Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall [PDF]

, 2018
Benign TdT-positive cells have been documented in a variety of non-hematopoietic tissues. Scant data are however available on their presence in non-neoplastic lymph nodes.
AGOSTINELLI, CLAUDIO, Bertuzzi, Clara, BRIGNOLA, STEFANO, Pillon, Marta, Pizzi, Marco, Righi, Simona, Rugge, Massimo, Sabattini, Elena, Semenzato, Gianpietro   +8 more
core   +1 more source

Comparison of referring and final pathology for patients with T‐cell lymphoma in the National Comprehensive Cancer Network [PDF]

, 2014
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107537/1/cncr28676 ...
A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma, Coiffier, d'Amore, Federico, Harris, LaCasce, O'Connor, Piccaluga, Piekarz, Pro, Proctor, Rodriguez, Rodriguez, Rudiger, Schetelig, Sibon, Smith, Vose, Weisenburger, Weisenburger, Younes   +20 more
core   +1 more source

Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma

Cancer Research, 2020
Deregulated T-cell receptor signaling is a critical molecular event in angioimmunoblastic T-cell lymphoma and can be targeted with dasatinib. Recurrent hotspot (p.Gly17Val) mutations in RHOA encoding a small GTPase, together with loss-of-function ...
Tran Nguyen, M. Sakata-Yanagimoto, M. Fujisawa, Sharna Tanzima Nuhat, H. Miyoshi, Y. Nannya, K. Hashimoto, K. Fukumoto, O. Bernard, Yusuke Kiyoki, Kantaro Ishitsuka, H. Momose, S. Sukegawa, A. Shinagawa, T. Suyama, Yuji Sato, Hidekazu Nishikii, N. Obara, Manabu Kusakabe, S. Yanagimoto, S. Ogawa, K. Ohshima, S. Chiba   +22 more
semanticscholar   +1 more source

Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment

Frontiers in Immunology, 2022
Background Angioimmunoblastic T-cell lymphoma (AITL) has a rich tumor microenvironment (TME) that typically harbors plenty of CD4+tumor infiltrating lymphocytes, (TIL)-T-cells (so called common AITL).
Zihang Chen, Qiqi Zhu, Xueqin Deng, W. Yao, Wenyan Zhang, Wei-ping Liu, Yuan Tang, Sha Zhao   +7 more
semanticscholar   +1 more source

Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma

Zhongliu Fangzhi Yanjiu, 2020
Objective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based
WEN Tingyu, GUI Lin, JIN Jun, ZHANG Wei, WANG Ting, SHI Yuankai, LIU Peng   +6 more
doaj   +1 more source

Angioimmunoblastic T‐cell lymphoma contains multiple clonal T‐cell populations derived from a common TET2 mutant progenitor cell

Journal of Pathology, 2019
Angioimmunoblastic T‐cell lymphoma (AITL) is a neoplastic proliferation of T follicular helper cells with clinical and histological presentations suggesting a role of antigenic drive in its development.
Wen-qing Yao, Fangtian Wu, Wenyan Zhang, S. Chuang, J. S. Thompson, Zi Chen, Shao-Wei Zhang, A. Clipson, Ming Wang, Hongxiang Liu, Hani Bibawi, Yuanxue Huang, Luis Campos, J. Grant, P. Wright, Hesham Ei-Daly, L. Rásó-Barnett, L. Farkas, G. Follows, Zi-fen Gao, A. Attygalle, M. Ashton-Key, Wei-ping Liu, M. Du   +23 more
semanticscholar   +1 more source